FR2409980A1
(fr)
*
|
1977-11-24 |
1979-06-22 |
Synthelabo |
Ethers de phenols et leur application en therapeutique
|
IT1147311B
(it)
*
|
1980-02-13 |
1986-11-19 |
Stabil Bioterapico Farmachim |
Eteri basici di 4-idrossi-benzofenoni con attivita' quali agenti betabloccanti e relativi procedimento di preparazione
|
ZW9881A1
(en)
*
|
1980-06-02 |
1981-12-23 |
Hoffmann La Roche |
Substituted phenoxyaminopropanol derivatives
|
DE3125870C2
(de)
*
|
1980-07-09 |
1994-09-15 |
William John Louis |
3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
|
CH643527A5
(en)
*
|
1980-10-24 |
1984-06-15 |
Ciba Geigy Ag |
Process for the preparation of 1-alkylamino-3-(4-(2-lower alkoxy-ethyl)phenoxy)-2-propanols
|
JPS57108047A
(en)
*
|
1980-11-06 |
1982-07-05 |
Sandoz Ag |
3-aminopropoxyphenyl derivative, manufacture and pharmaceutical composition containing same
|
FI76551C
(fi)
|
1980-11-06 |
1988-11-10 |
Sandoz Ag |
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.
|
US5347050A
(en)
*
|
1980-11-06 |
1994-09-13 |
Richard Berthold |
3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
|
DE3125636A1
(de)
*
|
1981-06-30 |
1983-01-13 |
Merck Patent Gmbh, 6100 Darmstadt |
1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol zur senkung des augeninnendrucks und ophtalmikum, enthalten diese verbindung
|
FR2512443A1
(fr)
*
|
1981-09-10 |
1983-03-11 |
Synthelabo |
Derives de phenoxy-3 propanol-2, leur preparation et leur application en therapeutique
|
DE3151201A1
(de)
*
|
1981-12-23 |
1983-07-28 |
Beiersdorf Ag, 2000 Hamburg |
Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte
|
US4450172A
(en)
*
|
1982-03-10 |
1984-05-22 |
E. I. Du Pont De Nemours And Company |
Antihypertensive polyhalohydroxyisopropyl phenylalka(e)noic acid esters of alkylaminohydroxypropyloxyphenylalkyl alcohols
|
FR2536390B1
(fr)
*
|
1982-11-22 |
1986-03-21 |
Synthelabo |
Isomere s du betaxolol, sa preparation et son application en therapeutique
|
US5166218A
(en)
*
|
1983-10-19 |
1992-11-24 |
Hoffmann-La Roche Inc. |
Phenoxypropanolamines and pharmaceutical compositions thereof
|
CA1262729A
(en)
*
|
1983-10-19 |
1989-11-07 |
Leo Alig |
Phenoxypropanolamines
|
NZ211815A
(en)
*
|
1984-05-15 |
1988-11-29 |
Warner Lambert Co |
Preparation of 1-((3,4-dimethoxyphenethyl)amino)-3- (3-tolyloxy)-2-propanol
|
GB8412864D0
(en)
*
|
1984-05-19 |
1984-06-27 |
Smith Kline French Lab |
Chemical compounds
|
US5554367A
(en)
*
|
1984-10-31 |
1996-09-10 |
Alcon Laboratories, Inc. |
Compositions for treatment of glaucoma
|
ES8609190A1
(es)
*
|
1985-02-07 |
1986-07-16 |
Pharma Investi S A |
Un procedimiento para preparar eteres fenolicos
|
US5095151A
(en)
*
|
1985-05-21 |
1992-03-10 |
American Home Products Corporation |
Preparation of propranolol hydrochloride macrocrystals
|
EP0252007A3
(de)
*
|
1986-06-28 |
1989-07-05 |
Ciba-Geigy Ag |
2-Propanolderivate als Korrosionsinhibitoren
|
US4694022A
(en)
*
|
1986-12-24 |
1987-09-15 |
Alcon Laboratories, Inc. |
Fatty acid salts of betaxolol useful in the treatment of glaucoma
|
DE3866984D1
(en)
*
|
1987-07-21 |
1992-01-30 |
Hoffmann La Roche |
Phenoxypropanolamine.
|
FR2672594B1
(fr)
*
|
1991-02-08 |
1994-07-01 |
Synthelabo |
Derives d'ethers de phenols, leur preparation et leur application en therapeutique.
|
NZ335566A
(en)
|
1995-10-10 |
2003-01-31 |
Univ Melbourne |
3-amino-propoxyphenyl derivatives (I) and use in treating cardiac conditions as a beta blocker
|
CA2193149C
(en)
*
|
1995-12-22 |
2002-04-23 |
David H. Donabedian |
Cationic therapuetic agents and delivery systems
|
US5942633A
(en)
*
|
1996-06-19 |
1999-08-24 |
Abbott Laboratories |
Process for the selective alkylation of betaxolol intermediates
|
US5731463A
(en)
*
|
1996-09-23 |
1998-03-24 |
Abbott Laboratories |
Selective alkylation of an alcohol substituted phenol compound
|
CA2330611A1
(en)
|
1998-05-22 |
1999-12-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Bifunctional molecules and therapies based thereon
|
US6258350B1
(en)
|
1999-01-20 |
2001-07-10 |
Alcon Manufacturing, Ltd. |
Sustained release ophthalmic formulation
|
BR0015938A
(pt)
|
1999-11-30 |
2002-08-27 |
Alcon Inc |
Uso de antagonistas beta-adrenoceptores para a fabricação de um medicamento para o tratamento de desordens da retina externa
|
JP2004511435A
(ja)
*
|
2000-07-27 |
2004-04-15 |
ファルマシア・コーポレーション |
うっ血性心不全の処置のための、エポキシ−ステロイド型アルドステロン拮抗薬とβ−アドレナリン作動性拮抗薬の併用療法
|
DE60234057D1
(de)
|
2001-07-25 |
2009-11-26 |
Raptor Pharmaceutical Inc |
Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
|
US7001615B1
(en)
|
2001-12-07 |
2006-02-21 |
Alcon, Inc. |
Sustained release ophthalmic, otic and nasal suspension
|
AP2005003232A0
(en)
|
2002-08-19 |
2005-03-31 |
Pfizer Prod Inc |
Combination therapy for hyperproliferative diseases.
|
GEP20084406B
(en)
*
|
2003-05-30 |
2008-06-25 |
Ranbaxy Lab Ltd |
Substituted pyrrole derivatives and their use as hmg-co inhibitors
|
CN1300079C
(zh)
*
|
2004-12-03 |
2007-02-14 |
南京大学 |
合成4-[2-(环丙基甲氧基)乙基]苯酚的新工艺
|
SI1889198T1
(sl)
|
2005-04-28 |
2015-02-27 |
Proteus Digital Health, Inc. |
Farma-informacijski sistem
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
AU2006313430B2
(en)
*
|
2005-11-08 |
2012-09-06 |
Ranbaxy Laboratories Limited |
Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
WO2008020314A2
(en)
*
|
2006-03-14 |
2008-02-21 |
Ranbaxy Laboratories Limited |
Statin stabilizing dosage formulations
|
AU2007274724B2
(en)
*
|
2006-07-14 |
2012-07-26 |
Ranbaxy Laboratories Limited |
Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof
|
US20080161324A1
(en)
*
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
MX2009002893A
(es)
|
2006-09-18 |
2009-07-10 |
Raptor Pharmaceutical Inc |
Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
|
US8404896B2
(en)
|
2006-12-01 |
2013-03-26 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
EP2130828A4
(de)
|
2007-02-28 |
2010-12-29 |
Asahi Kasei Pharma Corp |
Sulfonamidderivat
|
WO2008112287A1
(en)
*
|
2007-03-12 |
2008-09-18 |
Nektar Therapeutics |
Oligomer-beta blocker conjugates
|
EP2050441A1
(de)
*
|
2007-10-19 |
2009-04-22 |
Université Victor Segalen Bordeaux 2 |
Verwendung von Beta-Blockern für die Herstellung eines Medikaments zur Behandlung von Hämangiomen
|
US8987262B2
(en)
|
2007-10-19 |
2015-03-24 |
Universite de Bordeaux |
Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
|
JP2009040769A
(ja)
*
|
2008-07-09 |
2009-02-26 |
William John Louis |
3−アミノ−プロポキシフェニル誘導体(i)
|
WO2010095940A2
(en)
|
2009-02-20 |
2010-08-26 |
To-Bbb Holding B.V. |
Glutathione-based drug delivery system
|
NZ596876A
(en)
|
2009-05-06 |
2014-01-31 |
Lab Skin Care Inc |
Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
BR112015026513A2
(pt)
|
2013-04-17 |
2017-07-25 |
Pfizer |
derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
MX2021008533A
(es)
|
2019-01-18 |
2021-08-19 |
Astrazeneca Ab |
Inhibidores de la pcsk9 y metodos de uso de los mismos.
|